[코로나19 백신]
It is unknown whether the efficacy of the US clinical trial will be proven after April and until next month.
1st quarter vaccinations decreased from 1.3 million to 760,000… The burden of vaccination increased after the second quarter
Expert “There is no alternative vaccine, but high-risk group vaccination is postponed, post-storm fear”
○ Even at the end of March, vaccination for the elderly’Well’
On this day, the Korea Centers for Disease Control and Prevention (DMI) announced that it had decided to withhold AstraZeneca vaccination for those over 65 years old at the judgment of the affiliated vaccination committee. The number of elderly people whose vaccinations have been postponed by this decision reached 376,724.
The committee recognized the safety and death-preventing effects of the AstraZeneca vaccine. However, he said, “there is a lack of statistical evidence on the efficacy of the vaccine in the age group over 65,” he said. “If there is a controversy about the efficacy of the vaccine against the elderly, it may lower the vaccination rate.
The Agency for Disease Control and Prevention decided to re-determine whether to inoculate the AstraZeneca vaccine to the elderly by securing additional data, including data from US clinical trials, by the end of March. Among the subjects of the phase 3 clinical trial in the United States, about 22% of the elderly aged 65 or older are known to be of sufficient size to demonstrate the effect of the elderly. However, the final clinical trial is expected to be completed only in April. In a briefing on the day, Chung Eun-kyung said, “There will be (clinical) interim results or data on evaluating vaccine effectiveness after vaccination in countries where vaccination has already begun, such as the UK.” However, as this is not the final clinical result, controversy may continue.
○ Concerns about disruption to the entire vaccination schedule
○ Experts “Postponed vaccination without alternative”
Among experts, it is pointed out that delaying vaccination for the elderly with a high fatality rate can be a’handshake’ of the quarantine authorities. Joong-sik Eom, professor of infectious medicine at Gachon University Gil Hospital, said, “It is to delay vaccination for the elderly by 4 to 8 weeks without introducing an alternative vaccine. For that reason, the WHO also recommended that AstraZeneca be given if there is no other alternative.” Choi Won-seok, a professor of infectious medicine at Korea University Ansan Hospital, pointed out that “protecting the high-risk group and maintaining the medical system is the most important goal of vaccination,” and “we had to take a good look at which choice was more beneficial to the high-risk group.”
Meanwhile, there is controversy over the government’s decision to cover 70% of the cost of vaccination through health insurance. That is why it is not actually a’free vaccination’. The Ministry of Health and Welfare explained that “the insurance money can be used for the health and safety of health insurance subscribers.”
Image [email protected]Go to reporter page>Reporter Kim So-min
Copyright by dongA.com All rights reserved.
—
–